Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Rang in aandelen
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Aandeelprijs
$20.91
Marktkapitalisatie
$7.57B
Verandering (1 dag)
-8.26%
Verandering (1 jaar)
41.25%
Land
CN
Handel Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Categorie
Healthcare
Winst voor Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Winst in Jun 2026 TTM: $175.62M
Volgens de meest recente financiële verslagen van Asymchem Laboratories (Tianjin) Co., Ltd. bedraagt de huidige winst van het bedrijf $175.62M. In 2024 behaalde het bedrijf een winst van $146.92M, een daling ten opzichte van de winst van 2023, die $361.25M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Asymchem Laboratories (Tianjin) Co., Ltd. van 2011 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $175.62M | -4.48% |
| 2025 | $183.86M | 25.15% |
| 2024 | $146.92M | -59.33% |
| 2023 | $361.25M | -33.10% |
| 2022 | $540.01M | 187.71% |
| 2021 | $187.69M | 51.14% |
| 2020 | $124.18M | 38.67% |
| 2019 | $89.55M | 33.73% |
| 2018 | $66.96M | 3.22% |
| 2017 | $64.87M | 38.39% |
| 2016 | $46.88M | 52.55% |
| 2015 | $30.73M | 43.65% |
| 2014 | $21.39M | 28.73% |
| 2013 | $16.62M | 23.63% |
| 2012 | $13.44M | -5.39% |
| 2011 | $14.21M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $5.27B | 2,903.53% |
US
|
|
| $-3.09B | -1,857.74% |
US
|
|
| $-4.02B | -2,386.83% |
AU
|
|
| $2.85B | 1,520.36% |
BE
|
|
| $1.95B | 1,010.70% |
NL
|
